Patients on IVIG Therapy for Neurological Disorders Successfully Transitioned to SCIG Therapy
Canadian investigators at Ottawa Hospital have reported a very high success rate with a nurse-led individualized program to facilitate a smooth transition in patients with neurological disorders from chronic intravenous immune globulin (IVIG) to subcutaneous immune globulin (SCIG) treatment.
Scientists Uncover Breakthrough in Development of Universal Flu Vaccine
Researchers at the University of Melbourne have discovered immune cells that can fight all different kinds of the influenza (flu) virus.
Excellent Response to Therapeutic Plasma Exchange in Myasthenia Gravis Patients with or Without Autoantibodies
A study out of the University of Texas Southwestern Medical Center found a 96 percent response rate to treatment with therapeutic plasma exchange (PLEX) in a series of 58 consecutive myasthenia gravis (MG) patients, with no significant difference in response between those with or without autoantibodies.
CMS Launches Artificial Intelligence Health Outcomes Challenge
CMS has launched the Artificial Intelligence Health Outcomes Challenge, a three-stage competition to accelerate artificial intelligence solutions that will potentially be used by CMS’s Innovation Center.
FDA Implements Added Efforts to Tackle e-Cigarette Use and Addiction by Kids
The FDA is making efforts as part of its Youth Tobacco Prevention Plan to ensure no tobacco products are marketed to, sold to or used by kids.
Serum Albumin a Strong Predictor of Mortality in Sepsis: Two New Studies
Two studies suggest low serum albumin levels in patients with sepsis is associated with mortality.
CMS Finalizes Rule on Medicare Advantage Pay Raise Based on Patient Encounter Data
CMS has finalized its rule to give Medicare Advantage plans a 2.53 percent pay raise in 2020, up from its original plan to raise pay 1.59 percent.
New Voluntary Medicare Part D Demo Aims to Reduce Spending on High-Cost Drugs
CMS announced the Part D Payment Modernization Model to share in savings generated by reducing costs in the program’s catastrophic phase.
HHS Grants Awarded to Help Americans Access HIV/AIDS Care and Medication
In 2018, HHS awarded $2.34 billion in Ryan White HIV/AIDS Program grants to cities, counties, states and local community based organizations.
Accelerated Dosing Regimen Approved for Japanese Encephalitis Vaccine
Valneva USA has received FDA approval of an accelerated dosing regimen for IXIARO (Japanese encephalitis vaccine, inactivated, adsorbed).